The FDA approach to AI: Embracing innovation, ensuring safety MobileODT

The US Food and Drug Administration (FDA) has acknowledged the potential impact that artificial intelligence (AI) and machine learning (ML) can have on healthcare. The FDA has been hard at work on the cutting edge of how to regulate transformative AI to ensure patients have access to safe technology that saves lives. Vast amounts of health data are collected every day during routine medical procedures. The development of any form of machine learning relies upon high-quality pools of data to build the necessary algorithms. With so much data available to build algorithms from, the healthcare industry is an accessible field for AI to make a positive impact.